- Companies
- Fountain Life
Fountain Life Funding, Investors & Competitors
Fountain Life has raised $115M across 4 funding rounds, most recently a $18M Series B in August 2025.
Last Fountain Life funding round
$18M
Series B · Aug 2025
Cumulative funding Fountain Life raised
$115M
across 4 funding rounds
Key investors in Fountain Life
Eos Venture Partners
Tony Robbins
Peter Diamandis
Bhupendra Modi
Newcross Healthcare
Todd R. Wanek
About Fountain Life
Fountain Life is a longevity clinic offering AI-driven diagnostics including full-body MRI, CT scans, blood panels, and whole-genome sequencing. Dallas-headquartered Fountain Life pairs results with physician-led care teams for personalized prevention plans in cardiovascular, cancer, and metabolic health.
Founded
2020
HQ
Website
Status
Privately held
Customer focus
B2C
Revenue model
Services
Fountain Life Funding History
Fountain Life has raised a total of $115M across 4 funding rounds.
Fountain Life's first fundraising round was a $2M seed round in January 2021. The most recent completed round was a $18M Series B in August 2025.
Fountain Life funding rounds
| Date | Stage | Investors | Raised | Deal Summary |
|---|---|---|---|---|
| Aug 2025 | Series B | Eos Venture Partners (lead); Todd R. Wanek; Tony Robbins; Peter Diamandis; Bhupendra Modi | $18M | Fountain Life, a longevity-focused health company co-founded by Dr. William Kapp, Tony Robbins, and Dr. Peter Diamandis, raised $18 million in a Series B round on August 13-14, 2025, led by Eos Venture Partners with participation from existing board members and investors including Todd Wanek and B.K. Modi. The company originated from a 2020 merger between Kapp’s Longevity Performance Center in Naples, Florida, and Robbins and Diamandis’ Fountain Therapeutics stem cell startup. It operates centers in locations such as Naples, Westchester (New York), Orlando, and Dallas, specializing in early detection via advanced diagnostics like blood tests, full-body scans monitoring over 100 biomarkers, health optimization, and regenerative therapies, with results tracked via an AI-powered app called Zori. Membership is subscription-based and priced at around $30,000 annually for full services including quarterly testing and medical support, or $10,000-$10,500 for testing-only packages, with tiered programs like CORE, APEX, and EPIC. The company previously raised an $80 million Series A, bringing total funding to about $108 million. The new capital will fund expansion, including a Houston center opening in December 2025 and planned locations in Los Angeles and Miami for Q2 2026. Fountain Life aims to shift healthcare from reactive to proactive by making advanced diagnostics more accessible, planning to train external medical facilities on its methodologies to reduce costs. It positions itself in the growing preventive healthcare market driven by demand for early disease detection. |
| Nov 2023 | Series A | Eos Venture Partners (lead) | $80M | Fountain Life is a preventative health and longevity company founded in 2020 by Dr. William Kapp, Tony Robbins, Peter Diamandis, and others, focusing on transforming healthcare from reactive to proactive through precision diagnostics, AI technologies, and early detection of diseases like cancer, cardiac, metabolic, and neurodegenerative conditions. It operates centers in locations including Orlando, Dallas, Miami, Houston, and White Plains, offering tiered membership programs such as CORE, APEX, and EPIC with annual subscriptions priced at $21,500 or testing packages at $10,500, emphasizing predictive, preventive, personalized, and data-driven care. The company secured a $15M investment on December 15, 2022, from Eos Venture Partners and Newcross Healthcare to support U.S. and global expansion, integrated insurance business, and advancements in home care. Later, Fountain Life raised an $18M Series B in August 2025 led by Eos Venture Partners (EOS Ventures), with participation from board members like Todd Wanek and B.K. Modi, following a prior $80M Series A, bringing total funding to about $108M; funds aimed at expanding centers to Houston, Los Angeles, and Miami. The company positions itself in the longevity and InsurTech space, partnering with global insurers via Eos to impact healthcare access. |
| Dec 2022 | Series A | Eos Venture Partners (lead); Newcross Healthcare (lead) | $15M | Fountain Life is a preventative health and longevity company founded in 2020 by Tony Robbins, Peter Diamandis, Dr. Bob Hariri, and Dr. William Kapp, focused on transforming healthcare from reactive to proactive through precision diagnostics, AI technologies, and advanced testing to detect asymptomatic diseases early, including cancer, cardiac, metabolic, and neurodegenerative conditions. The company offers membership services via centers in locations such as Naples, FL; White Plains, NY; Dallas, TX; and Rishikesh, India, with tele-health options and plans for further U.S. and global expansion. It also operates an integrated health insurance business. On December 15, 2022, Fountain Life raised $15 million in venture funding from Eos Venture Partners and Newcross Healthcare to support its product development, geographic expansion, and transformation of the healthcare ecosystem, including enhanced home care availability. Eos Venture Partners, a leading InsurTech investor, and Newcross Healthcare, a UK-based expert in healthcare treatment and care at home, participated as strategic partners. The funding aims to democratize access to advanced medical technology and advance wellness-focused preventative diagnostics. |
| Jan 2021 | Seed | - | $2M | - |
Who has invested in Fountain Life?
6 investors have backed Fountain Life across its funding rounds, including Eos Venture Partners, Tony Robbins, Peter Diamandis, Bhupendra Modi, Newcross Healthcare and Todd R. Wanek.
Lead investors include Eos Venture Partners and Newcross Healthcare.
Fountain Life Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 3 | Lead | Dec 2022 | ||
| 1 | Participant | Aug 2025 | ||
| 1 | Participant | Aug 2025 | ||
| 1 | Participant | Aug 2025 | ||
This data is available for Pro users. Sign up to see all 6 Fountain Life investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAcquisitions by Fountain Life
Fountain Life has acquired 1 company to date.
Last acquisition by Fountain Life was on December 6th 2023. Fountain Life acquired LifeOmic for undisclosed valuation.
Latest Acquisitions by Fountain Life
| Description | LifeOmic is an Indianapolis-based software provider that builds the Precision Health Operating System for oncology and chronic disease management. Its cloud platform integrates machine learning to analyze patient data from electronic health records, wearables, and genomic sequencing. Healthcare providers use LifeOmic tools for clinical trial matching and remote patient monitoring. Researchers access de-identified datasets for studies on precision medicine. The company serves institutions like Indiana University Health and supports mobile apps for patient engagement. |
| HQ Country | |
| HQ City | Indianapolis, IN |
| Deal Date | 6 Dec 2023 |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Fountain Life acquisitions and their M&A valuation multiples. Start Free Trial | |
Fountain Life Competitors
Fountain Life competitors include listed companies like Revvity and JMDC, and private ones like Noom, Sword Health, Pristyn Care and Neko Health.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | $400M | - | $3.7B | 9.3x | ||
| Private | $240M | - | $4B | 16.7x | ||
| Private | $64M | - | $1.4B | - | ||
| Publicly listed | $2.9B | $735M | $16B | 6.6x | ||
| Private | - | - | $7B | - | ||
| Publicly listed | $324M | $88M | $1.5B | 4.6x |
Fountain Life Public Comps
Fountain Life is still privately-owned, but its public comps include Natera, IQVIA, Agilent, GE HealthCare, Quest Diagnostics, Labcorp, Guardant Health, Revvity, Solventum and Tempus AI.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $2.3B | ($266M) | 22.5x | 19.0x | (195.0x) | (261.5x) | |||
| $16B | $3.4B | 3.6x | 3.4x | 17.2x | 14.8x | |||
| $6.9B | $1.8B | 6.7x | 6.2x | 26.1x | 21.0x | |||
| $21B | $3.7B | 1.8x | 1.8x | 10.1x | 10.0x | |||
| $11B | $2.2B | 3.0x | 2.9x | 15.5x | 14.5x | |||
| $14B | $2B | 2.4x | 2.3x | 16.3x | 13.0x | |||
| $982M | ($408M) | 25.7x | 20.2x | (61.8x) | (129.5x) | |||
| $2.9B | $735M | 6.5x | 6.6x | 25.4x | 21.0x | |||
This data is available for Pro users. Sign up to see all Fountain Life competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Fountain Life
| When was Fountain Life founded? | Fountain Life was founded in 2020. |
| Where is Fountain Life headquartered? | Fountain Life is headquartered in United States. |
| Is Fountain Life publicly listed? | No, Fountain Life is a private, VC-backed company. |
| How much funding has Fountain Life raised? | Fountain Life has raised $115M across 4 funding rounds. |
| What was Fountain Life's last funding round? | Fountain Life's last funding round was a $18M Series B in August 2025, led by Eos Venture Partners. |
| Who are Fountain Life's investors? | Fountain Life's investors include Eos Venture Partners, Todd R. Wanek, Tony Robbins, Peter Diamandis, Newcross Healthcare and Bhupendra Modi. |
| Which companies are comparable to Fountain Life? | Companies comparable to Fountain Life include Noom, Sword Health, Pristyn Care, Revvity, Neko Health and JMDC. |
| How many companies has Fountain Life acquired? | Fountain Life has acquired 1 company, including LifeOmic. |
See companies similar to Fountain Life
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




